Clinical Trial: EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
Sponsor and Collaborators
Therapeutic Advances in Childhood Leukemia Consortium
Enzon Pharmaceuticals, Inc.
Contact
Contact: Jeannette van der Giessen, BA
323-361-8725
jvandergiessen@chla.usc.edu
Contact: Elena Eckroth
323-361-5429
eeckroth@chla.usc.edu
Principal Investigator
Study Chair: Elizabeth Raetz, MD New York University Medical Center
Study Chair: William Carroll, MD New York University Medical Center
ClinicalTrials.gov Identifier
NCT01186328